In future studies, we plan to plan to develop a human monoclonal antibody to HSP70-1A and further elucidate the detailed molecular mechanism that underlies the effects of the interaction between extracellular HSP70-1A and CLEC14a in tumor-bearing animal models. The gene discussed is HSPA1A; the disease is neoplasm.